Saralasin [saralasin]
- Terms
-
(Sar(1),Ala(8))ANGII
(Sar1,Val5,Ala8)Angiotensin II
1-Sar-8-Ala Angiotensin II
1-Sarcosine-8-Alanine Angiotensin II
Angiotensin II, Sar(1)-Ala(8)-
Angiotensin II, Sarcosyl(1)-Alanine(8)-
Sar-Arg-Val-Tyr-Val-His-Pro-Ala
Saralasin Acetate
Saralasin Acetate, Anhydrous
Saralasin Acetate, Hydrated
An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION.
- DUI
- D012504 MeSH Browser
- CUI
- M0019423
- CAS
- Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-
- Previous indexing
- Alanine (1974); Angiotensin II (1974); Sarcosine (1974)
- History note
- 1984(1978)
- Public note
- 1984; see ANGIOTENSIN II 1978-83; 1-SARCOSINE-8-ALANINE ANGIOTENSIN II was indexed under ANGIOTENSIN II 1975-77
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 1
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0